Alterity Therapeutics Files 6-K on Security Cessation
Ticker: PRNAF · Form: 6-K · Filed: Aug 1, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: securities-filing, regulatory-update, company-announcement
Related Tickers: ATH
TL;DR
ATH securities cessation reported in 6-K, check your holdings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on August 1, 2024, to report the cessation of securities for ATH. This filing is incorporated by reference into several of their existing Registration Statements on Form S-8 and Form F-3.
Why It Matters
This filing indicates a change in the company's securities status, which could impact investors and their holdings.
Risk Assessment
Risk Level: medium — Cessation of securities can signal significant corporate actions or financial distress, requiring investor attention.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ATH (company) — Ticker symbol for Alterity Therapeutics Limited
- August 1, 2024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form S-8 (document) — Incorporated Registration Statement
- Form F-3 (document) — Incorporated Registration Statement
FAQ
What is the specific reason for the cessation of ATH securities?
The filing states 'Notification of cessation of securities - ATH' as Exhibit 99.1, but the details of the cessation are not provided within the main 6-K text.
Which specific Registration Statements is this 6-K being incorporated into?
This 6-K is incorporated into Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia.
Does Alterity Therapeutics Limited file annual reports under Form 20-F or Form 40-F?
Alterity Therapeutics Limited indicates it files annual reports under Form 20-F.
What was the former name of Alterity Therapeutics Limited?
The former company name was PRANA BIOTECHNOLOGY LTD, with a date of name change on January 5, 2001.
Filing Stats: 191 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-08-01 07:06:03
Filing Documents
- ea0210404-6k_alterity.htm (6-K) — 13KB
- ea021040401ex99-1_alterity.htm (EX-99.1) — 33KB
- ex99-1_001.jpg (GRAPHIC) — 1KB
- 0001013762-24-003520.txt ( ) — 48KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Notification of cessation of securities - ATH 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: August 1, 2024 2